반려동물의 표적치료제에 대한 고찰

• 영문명: A Review of the Molecularly Targeted Therapeutics in Companion Animal
• 발행기관: 한국동물보건학회
• 저자명: 윤소라(Sorah Yoon)
• 간행물 정보: 『한국동물보건학회지』2권 4호, 179~189쪽, 전체 11쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2023.12.31

영문 초록

Advances in bioinformatics using next-generation sequencing have dramatically identified new molecules involved in the pathogenesis of various diseases. As a result, many molecularly targeted therapeutics have been developed in medicine including veterinary medicine. In the field of veterinary medicine, toceranib, a multikinase inhibitor was approved 2009 following masitinib, which was the first molecularly target drug approved in 2008. Toceranib is originally approved as a treatment for mast cell tumors, but has been shown to be effective in other tumors as well. Therefore, there is a lot of potential for approved anti-cancer drugs to be used to treat other another type of diseases such as neurodegenerative diseases. Immunotherapies and cancer vaccine are also emerging as targeted therapeutics. In this review, we will discuss the approved molecularly targeted drugs and high potential drugs currently in clinical trials.

목차

1. 서론

2. 본론

3. 결론

Conflict of interest

ORCID

REFERENCES

키워드

Molecular-targeted Potential drug Therapeutics Disease Veterinary medicine